ES2229673T3 - Ensayo para pronosticar alergia o inflamacion. - Google Patents
Ensayo para pronosticar alergia o inflamacion. Download PDFInfo
- Publication number
- ES2229673T3 ES2229673T3 ES99903464T ES99903464T ES2229673T3 ES 2229673 T3 ES2229673 T3 ES 2229673T3 ES 99903464 T ES99903464 T ES 99903464T ES 99903464 T ES99903464 T ES 99903464T ES 2229673 T3 ES2229673 T3 ES 2229673T3
- Authority
- ES
- Spain
- Prior art keywords
- epitopes
- antigen
- ige
- kit
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 43
- 230000007815 allergy Effects 0.000 title claims abstract description 37
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 35
- 238000012360 testing method Methods 0.000 title description 13
- 206010061218 Inflammation Diseases 0.000 title description 3
- 230000004054 inflammatory process Effects 0.000 title description 3
- 102000036639 antigens Human genes 0.000 claims abstract description 46
- 108091007433 antigens Proteins 0.000 claims abstract description 46
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 46
- 239000000427 antigen Substances 0.000 claims abstract description 45
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 42
- 230000000172 allergic effect Effects 0.000 claims abstract description 41
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 31
- 206010016946 Food allergy Diseases 0.000 claims abstract description 22
- 150000001413 amino acids Chemical class 0.000 claims abstract description 20
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 238000011156 evaluation Methods 0.000 claims abstract description 14
- 208000027866 inflammatory disease Diseases 0.000 claims abstract description 14
- 230000002797 proteolythic effect Effects 0.000 claims abstract description 12
- 208000004262 Food Hypersensitivity Diseases 0.000 claims abstract description 11
- 239000012634 fragment Substances 0.000 claims abstract description 11
- 235000020932 food allergy Nutrition 0.000 claims abstract description 9
- 238000004393 prognosis Methods 0.000 claims abstract description 7
- 235000013601 eggs Nutrition 0.000 claims description 44
- 235000018102 proteins Nutrition 0.000 claims description 19
- 235000013305 food Nutrition 0.000 claims description 16
- 230000009257 reactivity Effects 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 235000020232 peanut Nutrition 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 8
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 8
- 235000018262 Arachis monticola Nutrition 0.000 claims description 8
- 208000035475 disorder Diseases 0.000 claims description 7
- 210000000936 intestine Anatomy 0.000 claims description 6
- 230000000750 progressive effect Effects 0.000 claims description 6
- 208000015943 Coeliac disease Diseases 0.000 claims description 5
- 108010000912 Egg Proteins Proteins 0.000 claims description 5
- 102000002322 Egg Proteins Human genes 0.000 claims description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 4
- 241000238631 Hexapoda Species 0.000 claims description 4
- 208000008267 Peanut Hypersensitivity Diseases 0.000 claims description 4
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 235000014571 nuts Nutrition 0.000 claims description 4
- 208000011231 Crohn disease Diseases 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 201000010853 peanut allergy Diseases 0.000 claims description 3
- 235000014102 seafood Nutrition 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 108091005588 alkylated proteins Proteins 0.000 claims description 2
- 241000251468 Actinopterygii Species 0.000 claims 2
- 241001553178 Arachis glabrata Species 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 235000019688 fish Nutrition 0.000 claims 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
- 102000014171 Milk Proteins Human genes 0.000 claims 1
- 108010011756 Milk Proteins Proteins 0.000 claims 1
- 150000001875 compounds Chemical group 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 235000021239 milk protein Nutrition 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 4
- 102000018358 immunoglobulin Human genes 0.000 abstract description 4
- 229940072221 immunoglobulins Drugs 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract 2
- 238000010561 standard procedure Methods 0.000 abstract 1
- 108010064983 Ovomucin Proteins 0.000 description 61
- 230000027455 binding Effects 0.000 description 40
- 239000013566 allergen Substances 0.000 description 23
- 230000001186 cumulative effect Effects 0.000 description 15
- 239000012528 membrane Substances 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 13
- 208000004739 Egg Hypersensitivity Diseases 0.000 description 10
- 201000010860 egg allergy Diseases 0.000 description 9
- 244000105624 Arachis hypogaea Species 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 206010012438 Dermatitis atopic Diseases 0.000 description 7
- 201000008937 atopic dermatitis Diseases 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000002009 allergenic effect Effects 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 239000013568 food allergen Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 230000009610 hypersensitivity Effects 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000021245 dietary protein Nutrition 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 239000013610 patient sample Substances 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 108010032595 Antibody Binding Sites Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 230000030741 antigen processing and presentation Effects 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000001024 immunotherapeutic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241001203952 Feia Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013567 aeroallergen Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 208000010216 atopic IgE responsiveness Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7317198P | 1998-01-30 | 1998-01-30 | |
| US73171P | 1998-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2229673T3 true ES2229673T3 (es) | 2009-08-04 |
Family
ID=22112157
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99903464T Expired - Lifetime ES2229673T3 (es) | 1998-01-30 | 1999-01-28 | Ensayo para pronosticar alergia o inflamacion. |
| ES08005972T Expired - Lifetime ES2383002T3 (es) | 1998-01-30 | 1999-01-28 | Prueba pronóstica de alergia |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08005972T Expired - Lifetime ES2383002T3 (es) | 1998-01-30 | 1999-01-28 | Prueba pronóstica de alergia |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6238925B1 (enExample) |
| EP (2) | EP1939628B1 (enExample) |
| JP (1) | JP4292262B2 (enExample) |
| AT (2) | ATE550665T1 (enExample) |
| AU (1) | AU741635B2 (enExample) |
| CA (1) | CA2319317C (enExample) |
| DE (1) | DE69919327D1 (enExample) |
| ES (2) | ES2229673T3 (enExample) |
| WO (1) | WO1999039211A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10110838C2 (de) * | 2001-03-06 | 2003-04-03 | Mlu Halle Wittenberg | Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen |
| WO2002073209A2 (de) * | 2001-03-10 | 2002-09-19 | Affina Immuntechnik Gmbh | Verfahren zur identifikation von immunreaktiven epitopen auf proteinen |
| RU2214599C2 (ru) * | 2001-11-21 | 2003-10-20 | Самарский медицинский институт "РЕАВИЗ" | Способ выявления лиц, относящихся к группе риска по развитию аллергических заболеваний |
| MXPA05011409A (es) * | 2003-04-23 | 2005-12-12 | Medarex Inc | Composiciones y metodos para la terapia de enfermedad inflamatoria intestinal. |
| US7662381B2 (en) | 2004-06-21 | 2010-02-16 | Medarex, Inc. | Interferon alpha receptor 1 antibodies and their uses |
| US8859210B2 (en) * | 2008-10-17 | 2014-10-14 | Mead Johnson Nutrition Company | Method for identifying allergenic proteins and peptides |
| WO2010101255A1 (ja) * | 2009-03-05 | 2010-09-10 | 味の素株式会社 | クローン病診断試薬 |
| EP2478373B1 (en) * | 2009-09-14 | 2019-01-09 | Icahn School of Medicine at Mount Sinai | Methods for characterizing antibody binding affinity and epitope diversity in food allergy |
| WO2012135313A1 (en) * | 2011-03-28 | 2012-10-04 | University Of Massachusetts | Compositions and methods for detecting allergy to a-gal epitopes |
| EP2841098A4 (en) | 2012-04-23 | 2016-03-02 | Allertein Therapeutics Llc | NANOPARTICLES FOR THE TREATMENT OF ALLERGIES |
| EP3760223A1 (en) | 2013-04-03 | 2021-01-06 | N-Fold Llc | Nanoparticle composition for desensitizing a subject to peanut allergens |
| KR102202575B1 (ko) | 2013-12-31 | 2021-01-13 | 삼성전자주식회사 | 메모리 관리 방법 및 장치 |
| US11215615B2 (en) | 2014-04-03 | 2022-01-04 | AllerGenis LLC | Peptides, reagents and methods for detecting food allergy |
| SG11201705102QA (en) | 2014-11-14 | 2017-07-28 | Biomerica Inc | Compositions, devices, and methods of ibs sensitivity testing |
| EP3173789A1 (en) * | 2015-11-24 | 2017-05-31 | Helmholtz-Zentrum für Infektionsforschung GmbH | Method for differentiation of immune response in an individual |
| JP2019515275A (ja) * | 2016-04-26 | 2019-06-06 | バイオメリカ・インコーポレイテッドＢｉｏｍｅｒｉｃａ， Ｉｎｃ． | 潰瘍性大腸炎感受性試験の組成物、デバイスおよび方法 |
| US11686733B2 (en) * | 2016-05-13 | 2023-06-27 | Applied Medical Enzyme Research Institute Corporation | Method for collecting data to predict risk of developing allergies |
| RU2621312C1 (ru) * | 2016-06-15 | 2017-06-01 | Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) | Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста |
| KR102687458B1 (ko) * | 2016-06-16 | 2024-07-24 | 호유 가부시키가이샤 | 생선 알레르기의 항원 |
| CN109804247A (zh) | 2016-07-08 | 2019-05-24 | 拜尔梅里科有限公司 | 抑郁症敏感测试的组合物、设备以及方法 |
| CN110716055A (zh) * | 2019-09-11 | 2020-01-21 | 天津医科大学 | 过敏原特异性免疫球蛋白e致病活性检测试剂盒 |
| US11237164B2 (en) * | 2020-04-15 | 2022-02-01 | ProteinSimple | Method for measurement of total protein content and detection of protein via immunoassay in a microfluidic device |
| US20230324405A1 (en) * | 2020-09-07 | 2023-10-12 | Mitsubishi Gas Chemical Company, Inc. | Allergic disease determination method and determination system |
| JP7555788B2 (ja) * | 2020-10-30 | 2024-09-25 | アサヒグループホールディングス株式会社 | タンパク質の起源種判別方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736362A (en) * | 1990-10-26 | 1998-04-07 | The University Of Melbourne | Ryegrass pollen allergen |
| US5567594A (en) * | 1991-04-26 | 1996-10-22 | Enteron, L.P. | Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| US5480972A (en) * | 1992-10-30 | 1996-01-02 | The University Of Melbourne | Allergenic proteins from Johnson grass pollen |
| US5558869A (en) * | 1992-12-30 | 1996-09-24 | University Of Arkansas | Major peanut allergen ara h II |
| US5939283A (en) * | 1992-12-31 | 1999-08-17 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from dog dander and uses therefor |
-
1999
- 1999-01-28 DE DE69919327T patent/DE69919327D1/de not_active Expired - Lifetime
- 1999-01-28 ES ES99903464T patent/ES2229673T3/es not_active Expired - Lifetime
- 1999-01-28 AT AT08005972T patent/ATE550665T1/de active
- 1999-01-28 EP EP08005972A patent/EP1939628B1/en not_active Expired - Lifetime
- 1999-01-28 ES ES08005972T patent/ES2383002T3/es not_active Expired - Lifetime
- 1999-01-28 JP JP2000529614A patent/JP4292262B2/ja not_active Expired - Fee Related
- 1999-01-28 CA CA002319317A patent/CA2319317C/en not_active Expired - Fee Related
- 1999-01-28 AU AU23478/99A patent/AU741635B2/en not_active Ceased
- 1999-01-28 AT AT99903464T patent/ATE426170T1/de not_active IP Right Cessation
- 1999-01-28 US US09/238,448 patent/US6238925B1/en not_active Expired - Lifetime
- 1999-01-28 WO PCT/US1999/001832 patent/WO1999039211A1/en not_active Ceased
- 1999-01-28 EP EP99903464A patent/EP1051626B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2383002T3 (es) | 2012-06-15 |
| EP1051626B1 (en) | 2009-03-18 |
| AU2347899A (en) | 1999-08-16 |
| AU741635B2 (en) | 2001-12-06 |
| EP1939628A1 (en) | 2008-07-02 |
| ATE550665T1 (de) | 2012-04-15 |
| HK1032262A1 (en) | 2001-07-13 |
| JP4292262B2 (ja) | 2009-07-08 |
| CA2319317A1 (en) | 1999-08-05 |
| DE69919327T2 (de) | 2005-03-10 |
| US6238925B1 (en) | 2001-05-29 |
| DE69919327D1 (de) | 2009-11-26 |
| JP2002502039A (ja) | 2002-01-22 |
| EP1939628B1 (en) | 2012-03-21 |
| HK1120865A1 (en) | 2009-04-09 |
| EP1051626A1 (en) | 2000-11-15 |
| ATE426170T1 (de) | 2009-04-15 |
| CA2319317C (en) | 2006-04-18 |
| WO1999039211A1 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2229673T3 (es) | Ensayo para pronosticar alergia o inflamacion. | |
| Chatchatee et al. | Identification of IgE-and IgG-binding epitopes on αs1-casein: Differences in patients with persistent and transient cow's milk allergy | |
| US6858398B2 (en) | Saliva test for detection of food allergy and intolerance | |
| Järvinen et al. | Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy | |
| Lindberg et al. | Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. | |
| US20150168389A1 (en) | Methods Of Determining Allergen Response Using Microarray Immunoassay Techniques | |
| US20100086939A1 (en) | Determination method for allergic disease | |
| Aukrust et al. | Severe Hypersensitivity or Intolerance Reactions to Measles Vaccine in Six Children Clinical and Immunological studies | |
| Carroccio et al. | Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption | |
| ES2788389T3 (es) | Ensayo mejorado para el diagnóstico de alergia al cacahuete | |
| US7258994B2 (en) | Saliva immunoassay for detection of antibodies for cardiovascular disease | |
| US20140154257A1 (en) | Materials and methods for diagnosing and treating asthma and dietary Fru-AGEs related disorders including auto-immune and other diseases found to be associated with elevated RAGE. The specification describes methods to identify and make dietary derived advanced glycation end-products, known as Fru-AGEs, Fru-AGE-haptens, and Fru-AGE immune complexes, and to make monoclonal and polyclonal antibodies to this plurality of bio-molecules for use in immunoassays and for use as therapeutic agents | |
| Mandal et al. | Evaluation of ELISA and dot blots for the serodiagnosis of neurocysticercosis, in children found to have single or multiple enhancing lesions in computerized tomographic scans of the brain | |
| KR101510376B1 (ko) | 새우 알레르겐, 항새우 알레르겐 항체 및 그의 이용 | |
| García-Palacios et al. | Enzyme-linked immunosorbent assay, immunoblot analysis and RAST fluoroimmunoassay analysis of serum responses against crude larval antigens of Anisakis simplex in a Spanish random population | |
| Powell et al. | Absorption of food protein antigen in infants with food protein-induced enterocolitis | |
| Kochanowski et al. | Comparative analysis of excretory-secretory antigens of Anisakis simplex, Pseudoterranova decipiens and Contracaecum osculatum regarding their applicability for specific serodiagnosis of human anisakidosis based on IgG-ELISA | |
| Finn et al. | Serum IgG antibodies to gliadin and other dietary antigens in adults with atopic eczema | |
| US20100190182A1 (en) | Diagnostic composition and method for the detection of a trichinella infection | |
| US20030100035A1 (en) | Saliva immunoassay for detection of antibodies for autoimmune disease | |
| HK1032262B (en) | Prognostic allergy or inflammation test | |
| ES2198645T3 (es) | Procedimiento mejorado para diagnosticos de alergia. | |
| US20050277113A1 (en) | Saliva immunoassay for detection of exposure to infectious agents | |
| HK1120865B (en) | Prognostic allergy test | |
| Rinkinen et al. | Relationship between canine mucosal and serum immunoglobulin A (IgA) concentrations: Serum IgA does not assess duodenal secretory IgA |